74
Participants
Start Date
November 28, 2017
Primary Completion Date
September 18, 2018
Study Completion Date
September 18, 2018
Hyaluronic Acid Combined With Chondroitin Sulfate
"Subjects' participation in the study will last 26 weeks. The study includes 7 visits that consist of a Screening visit, three treatment visits and three follow-up visits.~Eligible subjects will undergo a Baseline visit (V1 at week 0) during which, after the confirmation of eligibility, assessments and ultrasound evaluation, the study subjects will be treated with the 1st injection of 2%Hyaluronic Acid and 2% chondroitin sulfate Subsequent treatments will be administered at weekly intervals during Visit 2 (V2 at week 1) and Visit 3 (Visit 3 at week 2) after the effectiveness assessments.~Study subjects will return for Follow-up visits 1 month (Visit 4 at week 6), 3 months (Visit 5 at week 14) and 6 months (Visit 6 at week 26) after the last injection"
Revmacentrum MUDr. Mostera,, Brno
Rheumatology, Polyclinic Lesná, Brno
Institute of rheumatology, Prague
University Hospital Motol, Department of Rheumatology of Children and Adults, Prague
Medical Plus, s.r.o, Uherské Hradiště
Lead Sponsor
Fidia Farmaceutici s.p.a.
INDUSTRY